These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 26444763)

  • 41. Discrepancy-Based Evidence for Loss of Thinking Abilities (DELTA): Development and Validation of a Novel Approach to Identifying Cognitive Changes.
    Asken BM; Thomas KR; Lee A; Davis JD; Malloy PF; Salloway SP; Correia S
    J Int Neuropsychol Soc; 2020 May; 26(5):464-479. PubMed ID: 31822312
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Structured Interview & Scoring Tool-Massachusetts Alzheimer's Disease Research Center (SIST-M): development, reliability, and cross-sectional validation of a brief structured clinical dementia rating interview.
    Okereke OI; Copeland M; Hyman BT; Wanggaard T; Albert MS; Blacker D
    Arch Neurol; 2011 Mar; 68(3):343-50. PubMed ID: 21403019
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Greater than the Sum of Its Parts: δ can be Constructed from Item Level Data.
    Royall DR; Palmer RF; Matsuoka T; Kato Y; Taniguchi S; Ogawa M; Fujimoto H; Okamura A; Shibata K; Nakamura K; Nakaaki S; Koumi H; Mimura M; Fukui K; Narumoto J
    J Alzheimers Dis; 2016; 49(2):571-9. PubMed ID: 26444760
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Independent effects of white matter hyperintensities on cognitive, neuropsychiatric, and functional decline: a longitudinal investigation using the National Alzheimer's Coordinating Center Uniform Data Set.
    Puzo C; Labriola C; Sugarman MA; Tripodis Y; Martin B; Palmisano JN; Steinberg EG; Stein TD; Kowall NW; McKee AC; Mez J; Killiany RJ; Stern RA; Alosco ML
    Alzheimers Res Ther; 2019 Jul; 11(1):64. PubMed ID: 31351489
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Word-list intrusion errors predict progression to mild cognitive impairment.
    Thomas KR; Eppig J; Edmonds EC; Jacobs DM; Libon DJ; Au R; Salmon DP; Bondi MW;
    Neuropsychology; 2018 Feb; 32(2):235-245. PubMed ID: 29528684
    [TBL] [Abstract][Full Text] [Related]  

  • 46. δ scores predict multiple neuropsychiatric symptoms.
    Royall DR; Palmer RF
    Int J Geriatr Psychiatry; 2020 Nov; 35(11):1341-1348. PubMed ID: 32584472
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Trajectories of health-related quality of life during the natural history of dementia: a six-wave longitudinal study.
    Yu H; Gao C; Zhang Y; He R; Zhou L; Liang R
    Int J Geriatr Psychiatry; 2017 Sep; 32(9):940-948. PubMed ID: 27388609
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Establishing robust cognitive dimensions for characterization and differentiation of patients with Alzheimer's disease, mild cognitive impairment, frontotemporal dementia and depression.
    Beck IR; Schmid NS; Berres M; Monsch AU
    Int J Geriatr Psychiatry; 2014 Jun; 29(6):624-34. PubMed ID: 24227657
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of education on the progression of early- versus late-stage mild cognitive impairment.
    Ye BS; Seo SW; Cho H; Kim SY; Lee JS; Kim EJ; Lee Y; Back JH; Hong CH; Choi SH; Park KW; Ku BD; Moon SY; Kim S; Han SH; Lee JH; Cheong HK; Na DL
    Int Psychogeriatr; 2013 Apr; 25(4):597-606. PubMed ID: 23207181
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gullibility may be a warning sign of Alzheimer's disease dementia.
    Yamaguchi T; Maki Y; Takatama M; Yamaguchi H
    Int Psychogeriatr; 2019 Mar; 31(3):363-370. PubMed ID: 29938625
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cognitive and functional progression in Alzheimer disease: A prediction model of latent classes.
    Haaksma ML; Calderón-Larrañaga A; Olde Rikkert MGM; Melis RJF; Leoutsakos JS
    Int J Geriatr Psychiatry; 2018 Aug; 33(8):1057-1064. PubMed ID: 29761569
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cognitive decline as an outcome and marker of progression toward dementia, in early preventive trials.
    Mura T; Coley N; Amieva H; Berr C; Gabelle A; Ousset PJ; Vellas B; Andrieu S;
    Alzheimers Dement; 2022 Apr; 18(4):676-687. PubMed ID: 34482607
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tracking Cognitive Decline in Amnestic Mild Cognitive Impairment and Early-Stage Alzheimer Dementia: Mini-Mental State Examination versus Neuropsychological Battery.
    Kim J; Na HK; Byun J; Shin J; Kim S; Lee BH; Na DL
    Dement Geriatr Cogn Disord; 2017; 44(1-2):105-117. PubMed ID: 28768247
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Progression of Alzheimer's disease as measured by Clinical Dementia Rating Sum of Boxes scores.
    Williams MM; Storandt M; Roe CM; Morris JC
    Alzheimers Dement; 2013 Feb; 9(1 Suppl):S39-44. PubMed ID: 22858530
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differences in instrumental activities of daily living between mild cognitive impairment and Alzheimer's disease: A study using a detailed executive function assessment.
    Maeshima S; Osawa A; Kondo I; Kamiya M; Ueda I; Sakurai T; Arai H
    Geriatr Gerontol Int; 2021 Dec; 21(12):1111-1117. PubMed ID: 34643324
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cognitive and Neuropsychiatric Correlates of Functional Impairment Across the Continuum of No Cognitive Impairment to Dementia.
    Burton RL; O'Connell ME; Morgan DG
    Arch Clin Neuropsychol; 2018 Nov; 33(7):795-807. PubMed ID: 29190312
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Aging is a weak but relentless determinant of dementia severity.
    Royall DR; Palmer RF
    Oncotarget; 2016 Mar; 7(12):13307-18. PubMed ID: 26930722
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Depressed mood and the incidence of Alzheimer's disease in the elderly living in the community.
    Devanand DP; Sano M; Tang MX; Taylor S; Gurland BJ; Wilder D; Stern Y; Mayeux R
    Arch Gen Psychiatry; 1996 Feb; 53(2):175-82. PubMed ID: 8629893
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Psychometric Properties of the Clinical Dementia Rating - Sum of Boxes and Other Cognitive and Functional Outcomes in a Prodromal Alzheimer's Disease Population.
    McDougall F; Edgar C; Mertes M; Delmar P; Fontoura P; Abi-Saab D; Lansdall CJ; Boada M; Doody R
    J Prev Alzheimers Dis; 2021; 8(2):151-160. PubMed ID: 33569561
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Measuring cognitive change in subjects with prodromal Alzheimer's disease.
    Mura T; Proust-Lima C; Jacqmin-Gadda H; Akbaraly TN; Touchon J; Dubois B; Berr C
    J Neurol Neurosurg Psychiatry; 2014 Apr; 85(4):363-70. PubMed ID: 23840054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.